UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.86 +0.84 (+1.08%) GOLD FUTURES
2,392.20 +32.30 (+1.37%) DOW
39,908.00 +349.89 (+0.88%) Bitcoin GBP
51,967.34 +3,428.39 (+7.06%)
Galectin Therapeutics, Inc. (GALT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 175.81M |
| Enterprise value | 224.16M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 207.70 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -4.04 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.72 |
| 52-week change 3 | 70.06% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 4.2700 |
| 52-week low 3 | 1.2800 |
| 50-day moving average 3 | 2.9398 |
| 200-day moving average 3 | 2.0951 |
Share statistics
| Avg vol (3-month) 3 | 184.48k |
| Avg vol (10-day) 3 | 180.95k |
| Shares outstanding 5 | 61.9M |
| Implied shares outstanding 6 | 67.14M |
| Float 8 | 42.72M |
| % held by insiders 1 | 31.12% |
| % held by institutions 1 | 12.42% |
| Shares short (30 Apr 2024) 4 | 3.12M |
| Short ratio (30 Apr 2024) 4 | 10.29 |
| Short % of float (30 Apr 2024) 4 | 10.54% |
| Short % of shares outstanding (30 Apr 2024) 4 | 5.04% |
| Shares short (prior month 28 Mar 2024) 4 | 2.25M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:6 |
| Last split date 3 | 23 Mar 2012 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -96.17% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -44.8M |
| Diluted EPS (ttm) | -0.7400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 25.66M |
| Total cash per share (mrq) | 0.41 |
| Total debt (mrq) | 71.81M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.77 |
| Book value per share (mrq) | -1.01 |
Cash flow statement
| Operating cash flow (ttm) | -32.97M |
| Levered free cash flow (ttm) | -20.68M |
© 2024 Yahoo. All rights reserved.